<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE paragraph PUBLIC "-//IFRS//DTD DITA Paragraph//EN" "../../../DocTypes/com.ifrs.doctype/dtd/paragraph.dtd"><paragraph id="IFRS12_B22" base="F16130969" principles="no"><paranum class="- topic/title paragraph/paranum "/><titlealts><navtitle>B22</navtitle></titlealts><prolog><data name="standard_number" value="IFRS&#xa0;12"/><data name="paranum" value="B22"/></prolog><body><p id="IFRS12_P0317">A structured entity often has some or all of the following features or attributes:</p><ol outputclass="static" id="IFRS12_L0051" base="F16130971" type="lower-alpha"><li><li_value>(a)</li_value> <p id="IFRS12_P0318" base="F16130972">restricted activities.</p></li><li><li_value>(b)</li_value> <p id="IFRS12_P0319" base="F16130974">a narrow and well&#x2011;defined objective, such as to effect a tax&#x2011;efficient lease, carry out research and development activities, provide a source of capital or funding to an entity or provide investment opportunities for investors by passing on risks and rewards associated with the assets of the structured entity to investors.</p></li><li><li_value>(c)</li_value> <p id="IFRS12_P0320" base="F16130976">insufficient equity to permit the structured entity to finance its activities without subordinated financial support.</p></li><li><li_value>(d)</li_value> <p id="IFRS12_P0321" base="F16130978">financing in the form of multiple contractually linked instruments to investors that create concentrations of credit or other risks (tranches).</p></li></ol></body></paragraph>